A Phase I Study to Evaluate the Safety,Pharmacokinetics,Pharmacodynamics,and Efficacy of TJ037130 in Adult Participants With Advanced Solid Tumors

NCT07715747 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

128

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumor
Metastatic Ovary Cancer
Metastatic Gastric Cancer
Metastatic Endometrial Carcinoma

Interventions

DRUG: TJ037130

Sponsor

TJ Biopharma Co., Ltd.